Anti‐nuclear matrix protein 2 antibody‐positive amyopathic dermatomyositis presenting in a patient with prostate cancer: A case report-Reference-Cited by-同舟云学术

Anti‐nuclear matrix protein 2 antibody‐positive amyopathic dermatomyositis presenting in a patient with prostate cancer: A case report

Published:2024-05 Issue:5 Volume:12 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Shan Divya M.¹^ORCID,Gupta Neha²,Ortega‐Loayza Alex G.³,Shea Sofia⁴,Nandan Abhishek²⁵

Affiliation:

1. School of Medicine Virginia Commonwealth University Richmond Virginia USA

2. Division of Rheumatology, Allergy and Immunology Virginia Commonwealth University School of Medicine Richmond Virginia USA

3. Department of Dermatology Oregon Health & Science University Portland Oregon USA

4. Dermatopathology Hunter Holmes McGuire Veterans Affairs Medical Center Richmond Virginia USA

5. Rheumatology Hunter Holmes McGuire Veterans Affairs Medical Center Richmond Virginia USA

Abstract

Key Clinical MessageNuclear matrix protein (NXP‐2) positive amyopathic dermatomyositis (DM) may present without classic symptoms like muscle weakness, dysphagia, and edema, and mimic conditions like cutaneous lupus. Given DM's association with malignancy and interstitial lung disease, prompt and accurate diagnosis is important. Testing for myositis‐specific antibodies aids diagnosis in ambiguous cases.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.8884

Reference29 articles.

1. Clinical presentation and evaluation of dermatomyositis

2. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features—a Comprehensive Review

3. Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups

4. Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis

5. Dermatomyositis: A Clinicopathological Study of 40 Patients